Skip to main content

Santiago Ramon y Cajal Agüeras

Institutions of which they are part

Head of group
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Santiago Ramon y Cajal Agüeras

Institutions of which they are part

Head of group
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Patologia molecular translacional

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Maria Rosa Somoza Lopez de Haro, Jordi Temprana Salvador, Teresa Moline Marimon, Jessica Camacho Soriano, Carmela Iglesias i Felip, Josep Castellví Vives, Elena Muro Blanc, Marta Cano Galietero, Elena Antima Martinez Saez, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Irene Sansano Valero, Trond Aasen , Stefan Hummer
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 01138
Duration: 01/01/2022 - 30/06/2025

Targeting extracelluar vesicel mediated intercellular communication as a novel approach to combat cancer metastasis.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Elena Muro Blanc, Elena Muro Blanc, Vicente Peg Camara, Stefan Hummer
Funding agency: Fundación Ramón Areces
Funding: 127486
Reference: CIVP21S13325
Duration: 06/07/2023 - 05/07/2026

IMPaCT

IP: Santiago Ramon y Cajal Agüeras
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 0.01
Reference: IMP20/00009/RAMONYCAJAL
Duration: 01/01/2021 - 31/12/2023

Targeting the MNK/eIF4E axis in cancer: a rational approach to enhance tumor sensitivity to chemo- and immunotherapy.

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Maria Rosa Somoza Lopez de Haro, Teresa Moline Marimon, Josep Castellví Vives, Marta Sese Faustino, Stefan Hummer
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI20/01687
Duration: 01/01/2021 - 31/12/2023

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Maria Josefa Azpiroz Franch

Maria Josefa Azpiroz Franch

Predoctoral researcher
Cardiovascular Diseases
Read more
Elena Vargas Accarino

Elena Vargas Accarino

Postdoctoral researcher
Liver Diseases
Read more
Natalia Avani Da Silva

Natalia Avani Da Silva

Gestió i Administració
Communication Unit
Communication Directorate
Read more
Piero Arturo Alberti Delgado

Piero Arturo Alberti Delgado

Predoctoral researcher
General Surgery
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.